BioSpace News Archive

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company’s candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the US Food and Drug Administration, FDA, facilitating its clinical development and path forwards to market.

Seikagaku Corporation, a Japanese pharmaceutical and medical device company focused on providing innovative drug discovery specializing in glycoscience, will be featured at the Convoy of Hope Orlando Community Event on July 27, 2019.

Kodiak Sciences Inc. announced positive interim results from the ongoing Phase 1b study of KSI-301, its investigational intravitreal anti-VEGF antibody biopolymer conjugate in patients with anti-VEGF treatment-naïve neovascular age-related macular degeneration, diabetic macular edema, and macular edema due to retinal vein occlusion.

The Honourable Mary Ng, Canada’s Minister of Small Business and Export Promotion, will be in Vancouver to announce the creation of an integrated market in the medtech industry.